Objectives: To investigate influence of metabolic syndrome on vibration perception threshold in first-degree relatives of type 2 diabetes who were not diagnosed with diabets before. Material and Methods: First-degree relatives of type 2 diabetes at the age of 40 - 60 s who had not been diagnosed with diabetes before were enrolled. Height, weight, waist circumference, hip circumference, blood pressure (systolic and diastolic blood pressure), body fat percentage, fasting plasma lipid, fasting plasma glucose, 2-hour blood glucose after 75 g oral glucose and vibration perception threshold were measured. Results: 58 subjects were diagnosed with the level of vibration perception threshold ≥ 16 V. Vibration perception threshold in the metabolic syndrome group was significantly higher than that in the non-metabolic syndrome group (P < 0.05). Vibration perception threshold increased with the increase of metabolic syndrome component. The group with ≥3 components of metabolic syndrome had a significantly higher level of vibration perception, as compared with that of group with 0 component, group with 1 component of metabolic syndrome (p < 0.01). Group with 2 components of metabolic syndrome had a significantly higher level of vibration perception threshold when comparing with group with 0 component (P < 0.05). Vibration perception threshold was positively correlated with weight, body mass index, waist circumference, systolic blood pressure, diastolic blood pressure, fasting plasma glucose and 2-hour blood glucose. Stepwise multiple regression analysis showed that there was a positive correlation between waist circumference, systolic blood pressure and vibration perception threshold. Conclusion: Some first-degree relatives of type 2 diabetes who have not been diagnosed with diabetes have high risk of peripheral neuropathy, especially those with metabolic syndrome. Waist circumference and blood pressure are the main factors affecting Vibration perception threshold levels. Early detection of vibration perception threshold should be performed in first-degree relatives of type 2 diabetes with metabolic syndrome. Waist circumference and blood pressure may be important risk factors of peripheral neuropathy for them.
References
[1]
Martin, C.L., Waberski, B.H., Pop-Busui, R., Cleary, P.A., Catton, S., Albers, J.W., Feldman, E.L. and Herman, W.H. (2010) Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes. Diabetes Care, 33, 2635-2641. https://doi.org/10.2337/dc10-0616
[2]
Yu, H. and Liu, J. (2011) Effect of Hyperuricemia on Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus and Its Relationship with Insulin Resistance. Chinese Journal of Diabetes, 3, 232-235.
[3]
Dahlin, L.B., Güner, N., Elding Larsson, H. and Speidel, T. (2015) Vibrotactile Perception in Finger Pulps and in the Sole of the Foot in Healthy Subjects among Children or Adolescents. PLoS ONE, 10, e0119753. https://doi.org/10.1371/journal.pone.0119753
[4]
Alberti, K.G., Zimmet, P. and Shaw, J. (2005) IDF Epidemiology Task Force Consensus Group. The Metabolic Syndrome New Worldwide Definition. Lancet, 366, 1059-1062.
[5]
Margolis, D.J., Malay, D.S., Hoffstad, O.J., Leonard, C.E., MaCurdy, T., de Nava, K.L., Tan, Y., Molina, T. and Siegel, K.L. (2011) Incidence of Diabetic Foot Ulcer and Lower Extremity Amputation among Medicare Beneficiaries, 2006 to 2008. Data Points Publication Series.
[6]
Shen, J., Liu, F., Zeng, H., Zhao, J.G., Zhao, W., Dong, Y. and Jia, W.P. (2009) Detection of Vibration Threshold and Its Influencing Factors in Patients with Type 2 Diabetes. Chinese Journal Diabetes Mellitus, 1, 440-443.
[7]
Wang, Q.S. and Yu, M. (2013) Clinical Characteristics of Type 2 Diabetes Patients with Different Risk Vibration Thresholds. Chinese Journal Diabetes, 21, 149-151.
[8]
Malik, R.A., Tesfaye, S., Newrick, P.G., Walker, D., Rajbhandari, S.M., Siddique, I., Sharma, A.K., Boulton, A.J., King, R.H., Thomas, P.K. and Ward, J.D. (2005) Sural Nerve Pathology in Diabetic Patients with Minimal But Progressive Neuropathy. Diabetologia, 48, 578-585. https://doi.org/10.1007/s00125-004-1663-5
[9]
Elliott, J., Tesfaye, S., Chaturvedi, N., Gandhi, R.A., Stevens, L.K., Emery, C. and Fuller, J.H. (2009) Large-Fiber Dysfunction in Diabetic Peripheral Neuropathy Is Predicted by Cardiovascular Risk Factors. Diabetes Care, 32, 1896-1900. https://doi.org/10.2337/dc09-0554
[10]
Chong, P.S. and Cros, D.P. (2004) Technology Literature Review: Quantitative Sensory Testing. Muscle Nerve, 29, 734-747. https://doi.org/10.1002/mus.20053
[11]
Jia, W., Shen, Q., Bao, Y.Q., Lu, J.X., Li, M. and Xiang, K.S. (2006) Detection of Diabetic Peripheral Neuropathy and Evaluation of Its Diagnostic Value. National Medical Journal of China, 86, 2707-2710.
[12]
Callaghan, B.C., Little, A.A., Feldman, E.L. and Hughes, R.A. (2012) Enhanced Glucose Control for Preventing and Treating Diabetic Neuropathy. Cochrane Database of Systematic Reviews, CD007543. https://doi.org/10.1002/14651858.CD007543.pub2
[13]
Tabak, A.G., Herder, C., Rathmann, W., Brunner, E.J. and Kivimaki, M. (2012) Prediabetes: A High-Risk State for Diabetes Development. The Lancet, 379, 2279-2290. https://doi.org/10.1016/S0140-6736(12)60283-9
[14]
Katon, J.G., Reiber, G.E. and Nelson, K.M. (2013) Peripheral Neuropathy Defined by Monofilament Insensitivity and Diabetes Status: NHANES 1999-2004. Diabetes Care, 36, 1604-1606. https://doi.org/10.2337/dc12-1102
[15]
Arif Malik, A., Qureshi, M. and Arooj, M. (2013) Assessment of Glucose Tolerance Test to Evaluate Diabetes in First Degree Relatives of Diabetics. Pakistan Journal of Medical and Health Sciences, 7, 976-978.
[16]
Zhang, Y., Luk, A.O.Y., Chow, E., Ko, G.T.C., Chan, M.H.M., Ng, M., Kong, A.P.S., Ma, R.C.W., Ozaki, R., So, W.Y., Chow, C.C. and Chan, J.C.N. (2017) High Risk of Conversion to Diabetes in First-Degree Relatives of Individuals with Young-Onset Type 2 Diabetes: A 12-Year Follow-up Analysis. Diabetic Medicine, 34, 1701-1709. https://doi.org/10.1111/dme.13516
[17]
Hu, X., He, X., Ma, X., Su, H., Ying, L., Peng, J., Wang, Y., Bao, Y., Zhou, J. and Jia, W. (2018) A Decrease in Serum 1,5-Anhydroglucitol Levels Is Associated with the Presence of a First-Degree Family History of Diabetes in a Chinese Population with Normal Glucose Tolerance. Diabetic Medicine, 35, 131-136. https://doi.org/10.1111/dme.13534
[18]
Dash, D.K., Choudhury, A.K., Singh, M., Mangaraj, S., Mohanty, B.K. and Baliarsinha, A.K. (2018) Effect of Parental History of Diabetes on Markers of Inflammation, Insulin Resistance and Atherosclerosis in First Degree Relatives of Patients with Type 2 Diabetes Mellitus. Diabetes & Metabolic Syndrome, 12, 285-289. https://doi.org/10.1016/j.dsx.2017.12.004
[19]
Callaghan, B.C., Xia, R., Banerjee, M., de Rekeneire, N., Harris, T.B., Newman, A.B., Satterfield, S., Schwartz, A.V., Vinik, A.I., Feldman, E.L. and Strotmeyer, E.S. (2016) Metabolic Syndrome Components Are Associated with Symptomatic Polyneuropathy Independent of Glycemic Status. Diabetes Care, 39, 801-807. https://doi.org/10.2337/dc16-0081
[20]
Cortez, M., Singleton, J.R. and Smith, A.G. (2014) Glucose Intolerance, Metabolic Syndrome, and Neuropathy. Handbook of Clinical Neurology, 126, 109-122. https://doi.org/10.1016/B978-0-444-53480-4.00009-6
[21]
Lee, C.C., Perkins, B.A., Kayaniyil, S., Harris, S.B., Retnakaran, R., Gerstein, H.C., Zinman, B. and Hanley, A.J. (2015) Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort. Diabetes Care, 38, 793-800. https://doi.org/10.2337/dc14-2585
[22]
Shen, Q., Jia, W.P., Bao, Y., Lu, J.X., Lu, H.J., Zuo, Y.H., Du, Y., Wu, X.L., Gu, H.L. and Xiang, K.S. (2009) Peripheral Neuropathy in Subjects with Diabetes Mellitus and Impaired Glucose Regulation in 2 Shanghai Communities: A Cross-Sectional Study. Shanghai Medical Journal, 32, 374-378.
[23]
Chen, X.Q., Bi, Y., Hu, Y., Tong, G.Y. and Zhu, D.L. (2011) Prevalence and Risk Factors of Diabetic Peripheral Neuropathy. Journal of Medical Postgraduate, 24, 1035-1038.
[24]
El Boghdady, N.A. and Badr, G.A. (2012) Evaluation of Oxidative Stress Markers and Vascular Risk Factors in Patients with Diabetic Peripheral Neuropathy. Cell Biochemistry and Function, 30, 328-334. https://doi.org/10.1002/cbf.2808
[25]
Brownlee, M. (2005) The Pathobiology of Diabetic Complications: A Unifying Mechanism. Diabetes, 54, 1615-1625. https://doi.org/10.2337/diabetes.54.6.1615
[26]
Groover, A.L., Ryals, J.M., Guilford, B.L., Wilson, N.M., Christianson, J.A. and Wright, D.E. (2013) Exercise-Mediated Improvements in Painful Neuropathy Associated with Prediabetes in Mice. Pain, 154, 2658-2667. https://doi.org/10.1016/j.pain.2013.07.052
